<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01479699</url>
  </required_header>
  <id_info>
    <org_study_id>OLE study</org_study_id>
    <nct_id>NCT01479699</nct_id>
  </id_info>
  <brief_title>Absorption and Metabolism of Olive Leaf Extract and Its Effect on Vascular Reactivity and Cytokine Concentrations</brief_title>
  <official_title>Absorption and Metabolism of Olive Leaf Extract and Its Effect on Vascular Reactivity and Cytokine Concentrations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Comvita UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Reading</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine how olive leaf is absorbed and metabolised and also
      whether it has any effect on the elasticity of blood vessels and the immune system.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine how olive leaf is absorbed and metabolised and also
      whether it has any effect on vascular function and cytokine concentrations.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Absorption and metabolism</measure>
    <time_frame>0. 0.5, 1, 1.5, 2, 3, 4, 6, 8 hours post ingestion (blood) 0, 0-4, 4-8 and 8-24 hours post ingestion (urine)</time_frame>
    <description>Olive leaf polyphenol metabolites measured in blood and urine samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vascular function</measure>
    <time_frame>0, 2, 4, 6 hours post ingestion (LDI) 0, 0.5, 1, 1.5, 2, 3, 4, 6 and 8 hours post ingestion (DVP)</time_frame>
    <description>Vascular function was assessed via two methods: Laser Doppler Iontophoresis (LDI) and Digital Volume Pulse (DVP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokine concentration</measure>
    <time_frame>0, 1, 3 and 6 hours post ingestion</time_frame>
    <description>Concentrations of IL-8, IL-1beta, IL-6, IL-10 and TNF-alpha will be measured in whole blood stimulated with LPS.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Absorption and Metabolism</condition>
  <condition>Effect on Vascular Function</condition>
  <condition>Effect on Cytokine Concentrations</condition>
  <arm_group>
    <arm_group_label>Placebo capsule</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Four placebo capsules containing safflower oil only</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Olive leaf extract capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Four olive leaf capsules. Each containing 4mg oleuropein plus safflower oil.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Olive leaf extract capsules</intervention_name>
    <description>Four capsules taken at baseline each containing 4mg oleuropein</description>
    <arm_group_label>Placebo capsule</arm_group_label>
    <arm_group_label>Olive leaf extract capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19-40 years, non-smokers, able to swallow capsules, have a Body Mass Index (BMI) of
             18.5-30, have a normal liver function and haematology and a max alcohol intake of &lt;21
             units/week

        Exclusion Criteria:

          -  Those who suffer from any form of disease, including endocrine disease, liver disease,
             diabetes mellitus, myocardial infarction, blood clotting disorder, reproductive
             disorder, gastrointestinal disease or a chronic gastrointestinal disorder.

          -  Individuals who are vegetarian, have dietary restrictions or on a weight reducing diet
             will not be recruited.

          -  Subjects who have been taking antibiotics in previous 3 months before study will not
             be included in the study

          -  Females who may be pregnant, or if of childbearing potential and are not using
             effective contraceptive precautions will be excluded.

          -  Blood pressure &gt; 150/90 mmHg

          -  Haemoglobin &lt; 125 g/l for male, &lt; 110 g/l for female

          -  Gamma GT (liver enzymes) &gt; 80 IU/l

          -  Cholesterol &gt; 6.5 mmol/l

          -  Had suffered a myocardial infarction or stroke in the previous 12 months

          -  On any lipid-modifying medication

          -  On any medication affecting blood clotting

          -  Individuals taking vitamin and/or fish oil supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremy PE Spencer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reading</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ian Rowland, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reading</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Parveen Yaqoob, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reading</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hugh Sinclair Unit of Human Nutrition, University of Reading</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG6 5SG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2011</study_first_submitted>
  <study_first_submitted_qc>November 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2011</study_first_posted>
  <last_update_submitted>November 22, 2011</last_update_submitted>
  <last_update_submitted_qc>November 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 24, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Reading</investigator_affiliation>
    <investigator_full_name>Jeremy Paul Edward Spencer</investigator_full_name>
    <investigator_title>Professor of Biochemistry</investigator_title>
  </responsible_party>
  <keyword>Olive leaf extract</keyword>
  <keyword>Polyphenols</keyword>
  <keyword>Vascular function</keyword>
  <keyword>Bioavailability</keyword>
  <keyword>Cytokines</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

